Aarti Industries, SRF: Key reasons why PhillipCapital has upgraded chemical stocks
Chemical stocks BSE NSE: The brokerage mentions that the segment has been witnessing increasing demand both on a sequential and quarterly basis, while there are expectations that the prices will likely remain steady.
Chemical stocks BSE NSE: The specialty chemicals segment is certainly not in its heyday. In the recently concluded December-ended quarter of FY24 (Q3 FY24), the companies in the space posted a mixed set of numbers. Some of the headwinds that the industry is facing are a decline in demand across end customers and export woes amid the Red Sea crisis.
Nevertheless, domestic brokerage PhillipCapital sees the sector as having hit its bottom. The brokerage mentions that the segment has been witnessing increasing demand sequentially. Besides, there are expectations that the prices will remain steady.
Stock
|
New rating | Old rating | Price Target | Potential upside/downside |
Aarti Industries | Buy | Neutral | Rs 760 | 17% |
SRF | Buy | Neutral | Rs 2700 | 11% |
Atul Ltd. | Neutral | Sell | Rs 5900 | -3% |
Vinati Organics | Neutral | Sell | Rs 1950 | 22% |
The brokerage maintains that the export segments of Aarti Industries, SRF, and Vinati Organics have witnessed a recovery.
As regards Aarti Industries, the brokerage has upgraded the stock to a ‘buy’ as the company has signed long-term contracts, while at the same time, it has also seen improvements in exports.
"Considering the visible sequential improvement, recovery in industry demand and multiple supply contracts signed recently, the brokerage upgraded its rating on the stock to BUY from Neutral by rolling forward its valuations to FY26 from Sept’25 and value the stock at Rs 760,' added the brokerage.
Secondly, the brokerage is bullish on SRF, given the resilience in the specialty chemical space as well as the recovery in demand for refrigerant gas in the US market. Furthermore, the company’s capex execution has also been robust.
For Atul Ltd., the brokerage maintained that life sciences has seen demand recovery at a robust pace of 40 per cent sequentially.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations
Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?
SBI 444-day FD vs PNB 400-day FD: Here's what general and senior citizens will get in maturity on Rs 3.5 lakh and 7 lakh investments in special FDs?
Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets
Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?
01:31 PM IST